Abstract
Development of Tat-fused drug binding protein to improve anti-cancer effect of mammalian target of rapamycin inhibitors
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have